蛋白酶激活受体2经RhoA信号抑制人内皮祖细胞增殖、迁移功能
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(81970016,81001428)


Protease ⁃activated receptor ⁃2 inhibits human endothelial progenitor cell proliferation and migration via RhoA signaling
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探究蛋白酶激活受体2(protease-activated receptor 2,PAR2)对人内皮祖细胞(endothelial progenitor cell,EPC) 功能的影响。方法:EPC予以PAR2天然激动剂类胰蛋白酶、合成激动剂SLIGKV-NH2、合成抑制剂FSLLRY-NH2处理,EdU、 Transwell实验观察EPC增殖、迁移,实时定量PCR、ELISA分析检测相关细胞因子及受体表达,免疫印迹法评估Ras同源家族成员A(Ras homolog family member A,RhoA)水平;同时给予RhoA特异性抑制剂Y-27632,观察PAR2活化效应可否被取消。结果:PAR2激动剂可剂量依赖性抑制EPC增殖及迁移(P < 0.05),下调血管内皮生长因子A、血管内皮生长因子受体2、基质细胞衍生因子1及趋化性细胞因子受体4等表达(P < 0.05),该效应可被PAR2抑制剂取消;活化PAR2可显著上调EPC RhoA表达 (P < 0.05),抑制PAR2活性可取消该效应;Y-27632可逆转PAR2激动剂导致的EPC 细胞增殖、迁移抑制(P < 0.05)。结论: PAR2经RhoA信号抑制EPC增殖、迁移功能,是极具潜力的内皮再生与血管生成调控靶点。

    Abstract:

    Objective:The present study aims to investigate the role of protease - activated receptor 2(PAR2)in the regulation of human endothelial progenitor cell(EPC)function. Methods:EPCs were stimulated with tryptase(a natural agonist of PAR2),SLIGKV- NH2(a synthetic agonist of PAR2)and FSLLRY-NH2(an antagonist of PAR2). Cell proliferation and migration were evaluated by EdU incorporation and Transwell model. Expression of the cytokines and receptors were estimated by real - time quantitative PCR and ELISA. Level of intercellular Ras homolog family member A(RhoA)was assessed by Western blot analysis. And RhoA antagonist Y- 27632 was also applied to determine whether the effects of PAR2 activation can be abolished by RhoA inhibition. Results:The agonists of PAR2 dramatically inhibited EPCs proliferation and migration in a dose - dependent manner(P < 0.05). PAR2 activation markedly suppressed the expression of vascular endothelial growth factor-A,vascular endothelial growth factor receptor-2,stromal cell- derived factor -1and C -X -C chemokine receptor type 4(P < 0.05). All these effects can be abolished by the PAR2 antagonist(P < 0.05). PAR2 activation increased the level of RhoA in EPCs,which was also repressed by FSLLRY-NH2(P < 0.05). Y-27632 notably reversed the influence of PAR2 activation on EPCs proliferation and migration(P < 0.05). Conclusion:The activation of PAR2 blunted EPCs proliferation and migration via RhoA signal,hinting a potential role of PAR2 as a novel target for the modulation of endothelial regeneration and vasculogenesis.

    参考文献
    相似文献
    引证文献
引用本文

顾圣玮,顾浩,马晴晴,姚欣,曾晓宁.蛋白酶激活受体2经RhoA信号抑制人内皮祖细胞增殖、迁移功能[J].南京医科大学学报(自然科学版),2023,(5):655-662

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-02-03
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-18
  • 出版日期:
通知关闭
郑重声明